Portal Hypertension Recruiting Phase 4 Trials for Spironolactone (DB00421)

Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions

IndicationStatusPhase
DBCOND0029015 (Portal Hypertension)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02907749Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in CirrhosisTreatment